60 Degrees Pharmaceuticals, Inc Common Stock
Price & Volume
Stats
See more52W Range | $1.22-$7.36 |
Market Cap | $3.9M |
Shares Short | 112,379 |
Financials
See moreRevenue (12 Mos) | $1.3M |
Revenue Growth (YoY) | -36.8% |
Gross Profit (12 Mos) | -$1.4M |
Diluted EPS | -$6.76 |
News
See moreYahoo Finance • 13 days ago
60 Degrees' Phase 2 B-Free Babesiosis Study Of ARAKODA Clears Safety Board Review
Yahoo Finance • 14 days ago
60 Degrees Pharmaceuticals Announces Positive Recommendation from Data Safety Monitoring Board for B-FREE Phase 2 Study of Tafenoquine for Treatment of Chronic Babesiosis Patients with Severe Fatigue
Yahoo Finance • 3 months ago
Praxis Precision Medicines Inc. (PRAX): Rare Triple-Catalyst Setup in Neurology
About
CEO | Dr. Geoffrey Stuart Dow Ph.D. |
CFO | Mr. Tyrone Miller |
Address | 1025 Connecticut Avenue NW, Washington, DC, United States, 20036 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 3 |